RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Robert Kirken to Lymphocyte Specific Protein Tyrosine Kinase p56(lck)

Back to Details
This is a "connection" page, showing publications Robert Kirken has written about Lymphocyte Specific Protein Tyrosine Kinase p56(lck).
Robert Kirken
Connection Strength
0.052
Lymphocyte Specific Protein Tyrosine Kinase p56(lck)
  1. Stepkowski SM, Erwin-Cohen RA, Behbod F, Wang ME, Qu X, Tejpal N, Nagy ZS, Kahan BD, Kirken RA. Selective inhibitor of Janus tyrosine kinase 3, PNU156804, prolongs allograft survival and acts synergistically with cyclosporine but additively with rapamycin. Blood. 2002 Jan 15; 99(2):680-9.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support